HAO:NSD-Haoxi Health Technology Limited Class A Ordinary Shares (USD)

COMMON STOCK | Advertising Agencies |

Last Closing

USD 1.4847

Change

-0.05 (-3.05)%

Market Cap

N/A

Volume

2.64K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap
ADVWW Advantage Solutions Inc

N/A

USD 3.69B
CRTO Criteo Sa

+0.09 (+0.32%)

USD 1.58B
STGW Stagwell Inc

-0.13 (-2.50%)

USD 1.57B
MGNI Magnite Inc

+0.21 (+1.41%)

USD 1.38B
ZD Ziff Davis Inc

-1.47 (-4.54%)

USD 1.37B
IAS Integral Ad Science Holding LL..

-0.07 (-0.90%)

USD 1.10B
QNST QuinStreet Inc

-0.78 (-4.99%)

USD 0.88B
NCMI National CineMedia Inc

+0.12 (+2.42%)

USD 0.54B
NEXN Nexxen International Ltd

+0.36 (+3.22%)

USD 0.49B
ADV Advantage Solutions Inc

+0.09 (+6.52%)

USD 0.42B

ETFs Containing HAO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Advertising Agencies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -58.12% 13% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.12% 13% F 8% B-
Trailing 12 Months  
Capital Gain -99.23% 4% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.23% 4% F 1% F
Trailing 5 Years  
Capital Gain -99.76% 8% B- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.76% 8% B- 2% F
Average Annual (5 Year Horizon)  
Capital Gain -16.51% 31% F 16% F
Dividend Return -16.51% 31% F 16% F
Total Return N/A 50% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 34.57% 72% C 52% F
Risk Adjusted Return -47.76% 34% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.